Loading...

NEO NEOGENOMICS INC Business Restructuring 8-K Filing

NGNM

N

NEOGENOMICS INC

(NEO)

2025 8-K

Show Summary

Show Summary

Management Changes

Bylaw Amendment

CEO Appointment

Management Changes

Management Changes

Earnings Announcement

Executive Bonuses

Board Appointment

Earnings Reports

Annual Meeting of Stockholders

Earnings Reports

Management Changes

Amendment and New Equity Aw...

Equity Award Agreement Appr...

Earnings Report

Earnings Report

Earnings Reports

Board Resignation and Appoi...

Annual Meeting of Stockholders

Equity Award Agreement and ...

Earnings Reports

Investor Conferences

Earnings Report

Resignation of Director

External Links:

On May 22, 2025, NeoGenomics, Inc. held its annual meeting where stockholders approved an amendment to its 2023 Equity Incentive Plan, increasing share issuance by 4.3 million shares and establishing a minimum one-year vesting period for awards. The

AI Assistant

NEOGENOMICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.